An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01001611 · COMPLETED
Trial details
- NCT number
- NCT01001611
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2012-01-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.